title: Ipratropium bromide for treatment of bethanechol-induced sialorrhea.
authors.forename: Arun R
authors.initials: AR
authors.lastname: Kunwar
authors.forename: Eleni
authors.initials: E
authors.lastname: Doufekias
authors.forename: Nikhil
authors.initials: N
authors.lastname: Nihalani
authors.forename: Mohammad M
authors.initials: MM
authors.lastname: Iqbal
mesh_terms: D000280:Administration, Inhalation; D000368:Aged; D018723:Bethanechol / Q000009:adverse effects*; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009241:Ipratropium / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D018721:Muscarinic Agonists / Q000009:adverse effects*; D012798:Sialorrhea / Q000139:chemically induced / Q000188:drug therapy*; D016055:Urinary Retention / Q000188:drug therapy
chemical_list: D018680:Cholinergic Antagonists; D018721:Muscarinic Agonists; D018723:Bethanechol; D009241:Ipratropium